This story originally ran on Oct. 12.
By Adam Bonislawski
Australian diagnostics firm Healthlinx noted in a September shareholder update that it would seek "to acquire distressed synergistic assets from a company in Chapter 11" as part of its US strategy.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.
Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.
MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.
Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.